bf/NASDAQ:CTMX_icon.png

COM:CYTOMX

CytomX Therapeutics

  • Stock

Last Close

0.99

31/10 14:17

Market Cap

102.07M

Beta: -

Volume Today

118.54K

Avg: -

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of brea...Show More

peer of